PTJ
ADPT icon

Paul Tudor Jones’s Adaptive Biotechnologies ADPT Stock Holding History

Paul Tudor Jones’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
543,485
-242,796
-31% -$3.72M 0.02% 747
2026
Q1 		$10.9M Buy
786,281
+232,244
+42% +$3.7M 0.02% 692
2025
Q4 		$9M Sell
554,037
-132,356
-19% -$2.16M 0.02% 812
2025
Q3 		$10.3M Sell
686,393
-174
-0% -$2.12K 0.02% 760
2025
Q2 		$8M Buy
686,567
+172,403
+34% +$1.57M 0.02% 791
2025
Q1 		$3.82M Buy
514,164
+55,676
+12% +$428K 0.01% 937
2024
Q4 		$2.75M Sell
458,488
-57,284
-11% -$316K 0.01% 1041
2024
Q3 		$2.64M Buy
515,772
+388
+0.1% +$1.69K 0.01% 1043
2024
Q2 		$1.87M Buy
515,384
+452,252
+716% +$1.44M 0.01% 1117
2024
Q1 		$203K Buy
+63,132
New +$244K ﹤0.01% 2041
2022
Q4 		– Sell
-134,337
Closed -$956K – 2314
2022
Q3 		$956K Buy
+134,337
New +$1.27M 0.02% 941
2022
Q1 		– Sell
-45,054
Closed -$1.26M – 1930
2021
Q4 		$1.26M Buy
45,054
+37,732
+515% +$1.16M 0.02% 874
2021
Q3 		$249K Sell
7,322
-29,221
-80% -$1.06M ﹤0.01% 2163
2021
Q2 		$1.49M Buy
36,543
+29,952
+454% +$1.16M 0.03% 686
2021
Q1 		$265K Buy
+6,591
New +$357K 0.01% 1345
2019
Q3 		– Sell
-5,000
Closed -$242K – 1055
2019
Q2 		$242K Buy
+5,000
New +$222K 0.01% 913

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paul Tudor Jones's ADPT Position: Q2 2026 in Review

Paul Tudor Jones reduced its Adaptive Biotechnologies (ADPT) stake by 31% in Q2 2026, selling an estimated $3.72M and leaving 543,485 shares worth $11.7M. The position accounts for 0.02% of the portfolio, ranked #747.

Paul Tudor Jones first reported a position in ADPT in Q2 2019 and has held it in 16 quarters since. 298 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Paul Tudor Jones held 543,485 shares of Adaptive Biotechnologies worth $11.7M as of Q2 2026.
  • Paul Tudor Jones sold 242,796 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.72M.
  • Adaptive Biotechnologies made up 0.02% of Paul Tudor Jones's portfolio in Q2 2026, its #747 holding.
  • Paul Tudor Jones first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 16 quarters since.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.